AstraZeneca Steadies Amid UK Inflation Concerns

AstraZeneca held steady in trading as London markets reacted to UK consumer price inflation increasing due to higher household energy costs.

The reading, which came in line with expectations, pushed interest rate expectations towards a less accommodative direction and hit domestically exposed sectors hardest.

However, pharmaceutical constituents like AstraZeneca were left to trade on their own fundamentals, as the drivers that matter for these companies are clinical readouts, regulatory approvals, label expansions, and the competitive shape of the treatment landscape.